File HF4064 ("State funds cell and gene therapy research study") is before the Minnesota Legislature and has not been decided. Latest step (April 20, 2026): Author added.
Minnesota file HF4064, before the Minnesota Legislature. Still to be decided as of 2026-04-20.
No immediate treatment access changes for patients This bill funds a study and report only; it does not expand access to cell or gene therapies, change coverage, or create new treatment programs during the study period.
May shape future state policy and industry growth The health commissioner's findings could inform future legislation on therapy approval, insurance coverage, clinical trial support, or incentives for biotech firms to develop or locate rare-disease treatments in Minnesota.
Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
Read the official record for HF4064
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk